These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 15937466)

  • 21. Increased Hsp27 after androgen ablation facilitates androgen-independent progression in prostate cancer via signal transducers and activators of transcription 3-mediated suppression of apoptosis.
    Rocchi P; Beraldi E; Ettinger S; Fazli L; Vessella RL; Nelson C; Gleave M
    Cancer Res; 2005 Dec; 65(23):11083-93. PubMed ID: 16322258
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New drugs target hypoxia response in tumors.
    Garber K
    J Natl Cancer Inst; 2005 Aug; 97(15):1112-4. PubMed ID: 16077066
    [No Abstract]   [Full Text] [Related]  

  • 23. Signal transducers and activators of transcription 3 activation is involved in nuclear accumulation of beta-catenin in colorectal cancer.
    Kawada M; Seno H; Uenoyama Y; Sawabu T; Kanda N; Fukui H; Shimahara Y; Chiba T
    Cancer Res; 2006 Mar; 66(6):2913-7. PubMed ID: 16540637
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Involvement of tyrosine kinases and STAT3 in Humanin-mediated neuroprotection.
    Hashimoto Y; Suzuki H; Aiso S; Niikura T; Nishimoto I; Matsuoka M
    Life Sci; 2005 Oct; 77(24):3092-104. PubMed ID: 16005025
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Survivin is a downstream target and effector of sulindac-sensitive oncogenic Stat3 signalling in head and neck cancer.
    Scheper MA; Nikitakis NG; Sauk JJ
    Int J Oral Maxillofac Surg; 2007 Jul; 36(7):632-9. PubMed ID: 17566705
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An introduction to molecular targeted therapy of cancer.
    Allgayer H; Fulda S
    Adv Med Sci; 2008; 53(2):130-8. PubMed ID: 18650147
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting MDC1-mediated homologous recombination and repair as a therapeutic possibility.
    Cancer Biol Ther; 2006 Jan; 5(1):8-9. PubMed ID: 16927454
    [No Abstract]   [Full Text] [Related]  

  • 28. A dominant negative form of p63 inhibits apoptosis in a p53-independent manner.
    Lee HO; Lee JH; Choi E; Seol JY; Yun Y; Lee H
    Biochem Biophys Res Commun; 2006 May; 344(1):166-72. PubMed ID: 16616891
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of Stat3 activation and tumor growth suppression of non-small cell lung cancer by G-quartet oligonucleotides.
    Weerasinghe P; Garcia GE; Zhu Q; Yuan P; Feng L; Mao L; Jing N
    Int J Oncol; 2007 Jul; 31(1):129-36. PubMed ID: 17549413
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Molecular markers having a prognostic or therapeutic value in cancer].
    Brousset P
    Ann Pathol; 2008 Nov; 28 Spec No 1(1):S69-70. PubMed ID: 18984307
    [No Abstract]   [Full Text] [Related]  

  • 31. Protein kinase Cepsilon interacts with signal transducers and activators of transcription 3 (Stat3), phosphorylates Stat3Ser727, and regulates its constitutive activation in prostate cancer.
    Aziz MH; Manoharan HT; Church DR; Dreckschmidt NE; Zhong W; Oberley TD; Wilding G; Verma AK
    Cancer Res; 2007 Sep; 67(18):8828-38. PubMed ID: 17875724
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeted cancer therapy: promise and reality.
    Klein S; Levitzki A
    Adv Cancer Res; 2007; 97():295-319. PubMed ID: 17419951
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rational drug design of G-quartet DNA as anti-cancer agents.
    Jing N; Sha W; Li Y; Xiong W; Tweardy DJ
    Curr Pharm Des; 2005; 11(22):2841-54. PubMed ID: 16101441
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rational targeting of Notch signaling in cancer.
    Rizzo P; Osipo C; Foreman K; Golde T; Osborne B; Miele L
    Oncogene; 2008 Sep; 27(38):5124-31. PubMed ID: 18758481
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of Stat3 increases doxorubicin sensitivity in a human metastatic breast cancer cell line.
    Gariboldi MB; Ravizza R; Molteni R; Osella D; Gabano E; Monti E
    Cancer Lett; 2007 Dec; 258(2):181-8. PubMed ID: 17920763
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel non-phosphorylated potential antitumoral peptide inhibits STAT3 biological activity.
    Dourlat J; Liu WQ; Sancier F; Edmonds T; Pamonsinlapatham P; Cruzalegui F; Garbay C
    Biochimie; 2009 Aug; 91(8):996-1002. PubMed ID: 19470402
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TAp63-dependent induction of growth differentiation factor 15 (GDF15) plays a critical role in the regulation of keratinocyte differentiation.
    Ichikawa T; Suenaga Y; Koda T; Ozaki T; Nakagawara A
    Oncogene; 2008 Jan; 27(4):409-20. PubMed ID: 17637746
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [New therapies against cancer].
    Salamanca-Gómez F
    Gac Med Mex; 2000; 136(6):625-6. PubMed ID: 11131865
    [No Abstract]   [Full Text] [Related]  

  • 39. Design and Development of Drugs Targeting Protein-Protein Interactions - Part-I.
    Gupta SP
    Curr Top Med Chem; 2019; 19(6):393. PubMed ID: 31184297
    [No Abstract]   [Full Text] [Related]  

  • 40. Outsmarting Cancer. A biologist talks about what makes disease-causing proteins so difficult to target with drugs.
    Stockwell B
    Sci Am; 2011 Oct; 305(4):20. PubMed ID: 22106796
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.